Cross tabulation revealed the levels of Cav-1 and pERK-1/2 to be significantly (P = 0.03) associated in the primary RCC tumours with 19% (29/158) of tumours showing co-expression. The gene discussed is CAV1; the disease is renal cell carcinoma.